248 related articles for article (PubMed ID: 9351542)
1. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).
Gupta SK; Douglas-Jones AG; Fenn N; Morgan JM; Mansel RE
Cancer; 1997 Nov; 80(9):1740-5. PubMed ID: 9351542
[TBL] [Abstract][Full Text] [Related]
2. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component.
Konar K; Chatterjee U; Dutta SK
Indian J Pathol Microbiol; 2001 Jul; 44(3):297-300. PubMed ID: 12024916
[TBL] [Abstract][Full Text] [Related]
4. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
5. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
Rudnicka L; Stachura J
Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
7. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
Giardina C; Serio G; Lepore G; Lettini T; Dalena AM; Pennella A; D'Eredità G; Valente T; Ricco R
J Exp Clin Cancer Res; 2003 Jun; 22(2):279-88. PubMed ID: 12866579
[TBL] [Abstract][Full Text] [Related]
8. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
[TBL] [Abstract][Full Text] [Related]
9. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
[TBL] [Abstract][Full Text] [Related]
10. Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?
Chagpar AB; McMasters KM; Sahoo S; Edwards MJ
Surgery; 2009 Oct; 146(4):561-7; discussion 567-8. PubMed ID: 19789013
[TBL] [Abstract][Full Text] [Related]
11. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
12. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma.
Crombie N; Rampaul RS; Pinder SE; Elston CW; Robertson JF; Ellis IO
Br J Surg; 2001 Oct; 88(10):1324-9. PubMed ID: 11578285
[TBL] [Abstract][Full Text] [Related]
13. Cytologic diagnosis and grading of ductal carcinoma in situ.
McKee GT; Tildsley G; Hammond S
Cancer; 1999 Aug; 87(4):203-9. PubMed ID: 10455208
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.
Maxhimer JB; Pesce CE; Stewart RA; Gattuso P; Prinz RA; Xu X
J Am Coll Surg; 2005 Mar; 200(3):328-35. PubMed ID: 15737842
[TBL] [Abstract][Full Text] [Related]
16. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
17. Minimal breast cancer: evaluation of histology and biological marker expression.
Dublin EA; Millis RR; Smith P; Bobrow LG
Br J Cancer; 1999 Jul; 80(10):1608-16. PubMed ID: 10408407
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component.
Lampejo OT; Barnes DM; Smith P; Millis RR
Semin Diagn Pathol; 1994 Aug; 11(3):215-22. PubMed ID: 7831533
[TBL] [Abstract][Full Text] [Related]
19. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.
MacAusland SG; Hepel JT; Chong FK; Galper SL; Gass JS; Ruthazer R; Wazer DE
Cancer; 2007 Dec; 110(12):2648-53. PubMed ID: 17960606
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]